Active Stock Alerts: Elizabeth Arden, Apple, FEI, Arrow Electronics, Rockwell Medical May 21st
Apple Inc. (NASDAQ:AAPL): Cowen said they believe Apple is on target for a September launch for the iPhone and views shares as cheap following the recent 20% pullback. Shares are Outperform rated.
Elizabeth Arden, Inc. (NASDAQ:RDEN): After Elizabeth Arden’s stock dropped 12% since April 20, BMO Capital thinks that the company will benefit from the repositioning of the Elizabeth Arden brand, which is now underway. The firm thinks that the company can generate long-term EPS growth of 20%+ and it maintains a $44 target on the shares.
FEI Co. (NASDAQ:FEIC): After conducting channel checks, Stifel Nicolaus believes that FEI’s fundamental outlook hasn’t changed recently, so the recent decline in the company’s stock creates a good buying opportunity. The firm maintains a $58 target and Buy rating.
Arrow Electronics, Inc. (NYSE:ARW): Stifel Nicolaus believes that the recent weakness in Arrow (NYSE:ARW) and Avnet (NYSE:AVT) appears to be pricing in big declines in the companies’ results, which Stifel doesn’t see as likely. The firm remains upbeat on both stocks and maintains Buy rating on them.
Rockwell Medical Technologies Inc. (NASDAQ:RMTI): After Fresenius reportedly improperly disclosed an elevated risk of cardiac arrest and death during therapy associated with the company’s dialysis buffer concentrate product, Rodman & Renshaw believes that the report may highlight the benefits of Rockwell’s citrate-based buffer, CitraPure. The firm thinks that the report may cause sales of CitraPure to increase, and it maintains a $16 target and Outperform rating on Rockwell.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.